IL6 and cancer: The articles were systematically assessed based on a subjective evaluation of the articles’ relevance and categorized into three groups: one group, including studies concerning IL-6 in patients with GI cancer, a second group, containing relevant background articles involving both reviews, in vitro and in vivo studies of IL-6 and other types of cancer, and a third group, containing excluded studies.